← SynDRA
LAQUINIMOD
SynDRA canonical compound SYN0002922 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | CXCL2 |
| Mechanism of action | immunosuppressant |
All known targets
- CXCL2
- NFKB1; NFKB2; RELA; RELB; REL
Mechanisms of action (all sources)
- immunosuppressant
- CXCL2 MODULATOR
- Modulator
ATC classes
- N07X · OTHER NERVOUS SYSTEM DRUGS
Cross-references
Synonyms
- nerventra
- laquinimod sodium
- ABR-215062 sodium
- TV-5600
- ABR-215062
- ABR-215062 FREE ACID
- TV-5600 FREE ACID
- Laquinamod
- Laquinimod sodium
- Laquinimod Sodium Salt
- UNII-4H914M0CSP
- Laquinimod sodium [USAN]
- TV 5600
- 4H914M0CSP
- ABR 215062 Sodium
- Laquinimod sodium (USAN)
- sodium 5-chloro-3-(ethyl(phenyl)carbamoyl)-1-methyl-2-oxo-1,2-dihydroquinolin-4-olate
- SAIK-MS compound
- SCHEMBL1991182
- CHEMBL2103814
- DTXSID50179538
- QCR-166
- JWHPPWBIIQMBQC-UHFFFAOYSA-M
- AKOS027326368
- FT-0670730
- D08938
- Sodium 5-chloro-3-(ethylphenylcarbamoyl)-1-methyl-2-oxo-1,2-dihydroquinolin- 4-olate
- 3-Quinolinecarboxamide, 5-chlo
- 5-CHLORO-N-ETHYL-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE
- ABR 215062
- 5-Chloro-4-hydroxy-1-methyl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acid ethyl-phenyl-amide
- UNII-908SY76S4G
- CIVENTICHEM CV-4057
- Laquinimod (ABR-215062)
- 908SY76S4G
- N-Ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide
- 5-chloro-n-ethyl-2-hydroxy-1-methyl-4-oxo-n-phenyl-1,4-dihydroquinoline-3-carboxamide
- C19H17ClN2O3
Look up LAQUINIMOD in the interactive SynDRA portal →